Michael Adam Fischer, MD, MS

Professor, Medicine

Michael Fischer
617.414.7288
801 Massachusetts Ave

Biography

Michael Fischer, MD, MS is Chief of the Section of General Internal Medicine at Boston Medical Center/Chobanian and Avedisian School of Medicine. He is a primary care physician and health services researcher with expertise in developing and evaluating interventions to increase the use of evidence-based medical practices.

Dr. Fischer began his career at Brigham and Women’s Hospital, conducting research evaluating medication adherence; the appropriate use of prescription drugs; dissemination and implementation of evidence-based practices; prescription drug reimbursement policy; and the impact of electronic prescribing. He is the Director of the National Resource Center for Academic Detailing (www.NaRCAD.org), an initiative supported by the Agency for Health Care Research and Quality and the Centers for Disease Control and Prevention to assist organizations implementing interventions to improve health care quality and patient outcomes.

Other Positions

  • Section Chief, General Internal Medicine, Medicine, Boston University Chobanian & Avedisian School of Medicine

Education

  • Yale University School of Medicine, MD
  • Harvard School of Public Health, MS
  • Harvard College, AB

Publications

  • Published on 5/14/2024

    Ladines-Lim JB, Fischer MA, Linder JA, Chua KP. Appropriateness of Antibiotic Prescribing in US Emergency Department Visits, 2016-2021. Antimicrob Steward Healthc Epidemiol. 2024; 4(1):e79. PMID: 38751940.

    Read at: PubMed
  • Published on 4/26/2024

    Ladines-Lim JB, Fischer MA, Linder JA, Chua KP. Prevalence of Inappropriate Antibiotic Prescribing with or without a Plausible Antibiotic Indication among Safety-Net and Non-Safety Net Populations. J Gen Intern Med. 2024 Apr 26. PMID: 38671203.

    Read at: PubMed
  • Published on 4/22/2024

    Chua KP, Fischer MA, Rahman M, Linder JA. Changes in the Appropriateness of US Outpatient Antibiotic Prescribing After the Coronavirus Disease 2019 Outbreak: An Interrupted Time Series Analysis of 2016-2021 Data. Clin Infect Dis. 2024 Apr 22. PMID: 38648159.

    Read at: PubMed
  • Published on 11/20/2023

    Cromer SJ, Steiner B, York C, Mastrorilli J, Lake GA, Leibowitz S, Simmons L, Steppel-Reznik J, Low G, Fischer MA, Patorno E, Wexler DJ. Successful implementation of a stakeholder engagement program for pharmacoepidemiologic research. Pharmacoepidemiol Drug Saf. 2024 Jan; 33(1):e5727. PMID: 37985010.

    Read at: PubMed
  • Published on 7/27/2023

    Brown T, Lee JY, Guzman A, Fischer MA, Friedberg MW, Chua KP, Linder JA. Prevalence and appropriateness of in-person versus not-in-person ambulatory antibiotic prescribing in an integrated academic health system: A cohort study. PLoS One. 2023; 18(7):e0289303. PMID: 37498818.

    Read at: PubMed
  • Published on 3/1/2023

    Hendricks MA, El Ibrahimi S, Ritter GA, Flores D, Fischer MA, Weiss RD, Wright DA, Weiner SG. Association of Household Opioid Availability With Opioid Overdose. JAMA Netw Open. 2023 Mar 01; 6(3):e233385. PMID: 36930154.

    Read at: PubMed
  • Published on 11/9/2022

    Evins AE, Cather C, Maravic MC, Reyering S, Pachas GN, Thorndike AN, Levy DE, Fung V, Fischer MA, Schnitzer K, Pratt S, Fetters MD, Deeb B, Potter K, Schoenfeld DA. A Pragmatic Cluster-Randomized Trial of Provider Education and Community Health Worker Support for Tobacco Cessation. Psychiatr Serv. 2023 Apr 01; 74(4):365-373. PMID: 36349498.

    Read at: PubMed
  • Published on 11/4/2022

    Guzman A, Brown T, Lee JY, Fischer MA, Friedberg MW, Chua KP, Linder JA. Look-Back and Look-Forward Durations and the Apparent Appropriateness of Ambulatory Antibiotic Prescribing. Antibiotics (Basel). 2022 Nov 04; 11(11). PMID: 36358209.

    Read at: PubMed
  • Published on 10/28/2022

    Haff N, Choudhry NK, Isaac T, Bhatkhande G, Jackevicius CA, Fischer MA, Solomon DH, Sequist TD, Lauffenburger JC. Disagreement between pharmacy claims and direct interview to identify patients with non-adherence to chronic cardiometabolic medications. Am Heart J. 2023 Feb; 256:51-59. PMID: 36780373.

    Read at: PubMed
  • Published on 10/4/2022

    Wang J, Gagne JJ, Kattinakere-Sreedhara S, Fischer MA, Bykov K. Association between initiation of fluoroquinolones and hospital admission or emergency department visit for suicidality: population based cohort study. BMJ. 2022 Oct 04; 379:e069931. PMID: 36195324.

    Read at: PubMed

View 162 more publications: View full profile at BUMC

View all profiles